With computed tomography of lung adenocarcinoma, it is already possible to link mutational status (EGFR, KRAS, and ALK) with imaging-assessed characteristics, such as lymphangitis, pleural effusion, or lung metastases [94]. This evidence concerns the gene EGFR and lung adenocarcinoma.